So how does interpace plan to compete with Afirma GSC? Veracyte is already dominating this space, pretty disappointed with Q2 numbers
It's obvious Pancreas and Thyroid are not going to get it done. Hear this Stover, investors are not going to support you anymore unless you provide a Barregen launch plan...and soon too. Stop burning cash, its obvious your current products are not penetrating the market as they should.
They just need a marketing department. Who ever heard of a company NOT having a marketing department to support sales. Especially since there is so much competition. You either hire more reps or get someone to support them.
